ES428226A1 - 1,3-oxygenated 8alpha-oestratrienes - Google Patents
1,3-oxygenated 8alpha-oestratrienesInfo
- Publication number
- ES428226A1 ES428226A1 ES428226A ES428226A ES428226A1 ES 428226 A1 ES428226 A1 ES 428226A1 ES 428226 A ES428226 A ES 428226A ES 428226 A ES428226 A ES 428226A ES 428226 A1 ES428226 A1 ES 428226A1
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- oestratrienes
- 8alpha
- oxygenated
- oestraoligoene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
Abstract
1,3-Dihydroxy-1,3,5(10)-8alpha-oestratrienes or their ethers or esters of the following formula < IMAGE > in which the substituents are defined in Claim 1 are prepared. The said compounds are obtained by hydrogenating the 8(9) and, if present, the 14(15) double bond in a corresponding oestraoligoene. It is possible in the resulting compounds to reduce a 17-ketone group, to eliminate ester and ether groups, to esterify or etherify free hydroxyl groups and, furthermore, react a 17-ketone compound with organometallic compounds to introduce a hydrocarbon radical. The said compounds display favourable oestrogenic dissociation and they can be used for the treatment of manifestations of oestrogen deficiency.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2336431A DE2336431C2 (en) | 1973-07-13 | 1973-07-13 | 1.3-oxygenated 8-alpha-estratrienes, processes for their production and pharmaceuticals containing them |
DE19742426777 DE2426777A1 (en) | 1974-05-31 | 1974-05-31 | 1,3-Oxygenated-8-alpha-oestratrienes for post-menopausal disorders - with vaginotropic, but low uterotrophic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
ES428226A1 true ES428226A1 (en) | 1976-07-16 |
Family
ID=25765510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES428226A Expired ES428226A1 (en) | 1973-07-13 | 1974-07-12 | 1,3-oxygenated 8alpha-oestratrienes |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5821639B2 (en) |
AT (1) | ATA575574A (en) |
AU (1) | AU477010B2 (en) |
CA (1) | CA1030951A (en) |
CH (2) | CH609064A5 (en) |
CS (2) | CS182260B2 (en) |
DD (1) | DD114066A5 (en) |
DK (1) | DK133051C (en) |
ES (1) | ES428226A1 (en) |
FI (1) | FI54131C (en) |
FR (1) | FR2236505B1 (en) |
GB (1) | GB1479934A (en) |
HU (1) | HU169791B (en) |
IE (1) | IE39872B1 (en) |
IL (1) | IL45259A (en) |
NO (1) | NO742546L (en) |
SE (1) | SE7409151L (en) |
SU (1) | SU626705A3 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2551214C2 (en) * | 1975-11-12 | 1984-07-12 | Schering AG, 1000 Berlin und 4709 Bergkamen | Process for the preparation of 1,3-oxygenated 8α-estatrienes |
JPS5862734U (en) * | 1981-10-22 | 1983-04-27 | 日工株式会社 | formwork support sabot |
JPS59146759A (en) * | 1984-01-06 | 1984-08-22 | 株式会社日立製作所 | Automatic screwing device |
JPS60155376A (en) * | 1984-01-24 | 1985-08-15 | 松下電器産業株式会社 | Nut float detection apparatus |
DE3710728A1 (en) * | 1987-03-31 | 1988-10-13 | Schering Ag | METHOD FOR PRODUCING 17 (ALPHA) -ETHINYL-17SS-HYDROXY-18-METHYL-4.15-ESTRADIEN-3-ON AND THE NEW INTERMEDIATE PRODUCTS FOR THIS METHOD |
US6476011B1 (en) | 1991-08-28 | 2002-11-05 | Sterix Limited | Methods for introducing an estrogenic compound |
US6011024A (en) | 1991-08-28 | 2000-01-04 | Imperial College Of Science Technology & Medicine | Steroid sulphatase inhibitors |
US6903084B2 (en) | 1991-08-29 | 2005-06-07 | Sterix Limited | Steroid sulphatase inhibitors |
US7335650B2 (en) | 2000-01-14 | 2008-02-26 | Sterix Limited | Composition |
GB0020498D0 (en) | 2000-08-18 | 2000-10-11 | Sterix Ltd | Compound |
RU2679625C1 (en) * | 2018-11-08 | 2019-02-12 | Ильясов Шамиль Сионович | 3-o-sulfamoiloxy-6-oxa-7β-methyl-d-homo-8α-estra-1,3,5(10)-trien-17α-one application for the breast cancer treatment, including the triple negative form, and its production method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3436411A (en) * | 1967-12-28 | 1969-04-01 | American Home Prod | Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof |
-
1974
- 1974-07-09 DK DK368074A patent/DK133051C/en not_active IP Right Cessation
- 1974-07-11 DD DD179870A patent/DD114066A5/xx unknown
- 1974-07-11 AU AU71123/74A patent/AU477010B2/en not_active Expired
- 1974-07-11 IE IE1461/74A patent/IE39872B1/en unknown
- 1974-07-11 AT AT575574A patent/ATA575574A/en not_active Application Discontinuation
- 1974-07-11 SE SE7409151A patent/SE7409151L/en unknown
- 1974-07-12 CA CA204,667A patent/CA1030951A/en not_active Expired
- 1974-07-12 CH CH964674A patent/CH609064A5/en not_active IP Right Cessation
- 1974-07-12 ES ES428226A patent/ES428226A1/en not_active Expired
- 1974-07-12 NO NO742546A patent/NO742546L/no unknown
- 1974-07-12 CS CS7400004984A patent/CS182260B2/en unknown
- 1974-07-12 CS CS7600001694A patent/CS182300B2/en unknown
- 1974-07-12 CH CH1035978A patent/CH614217A5/en not_active IP Right Cessation
- 1974-07-12 JP JP49080116A patent/JPS5821639B2/en not_active Expired
- 1974-07-12 FI FI2139/74A patent/FI54131C/en active
- 1974-07-12 SU SU742043783A patent/SU626705A3/en active
- 1974-07-12 HU HU74@@E480A patent/HU169791B/en unknown
- 1974-07-14 IL IL45259A patent/IL45259A/en unknown
- 1974-07-15 FR FR7424499A patent/FR2236505B1/fr not_active Expired
- 1974-07-15 GB GB31241/74A patent/GB1479934A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA1030951A (en) | 1978-05-09 |
DD114066A5 (en) | 1975-07-12 |
DK368074A (en) | 1975-03-17 |
JPS5821639B2 (en) | 1983-05-02 |
NO742546L (en) | 1975-02-10 |
SU626705A3 (en) | 1978-09-30 |
GB1479934A (en) | 1977-07-13 |
IE39872L (en) | 1975-01-13 |
SE7409151L (en) | 1975-01-14 |
DK133051C (en) | 1976-08-16 |
CH614217A5 (en) | 1979-11-15 |
IL45259A0 (en) | 1974-10-22 |
FI54131C (en) | 1978-10-10 |
CS182300B2 (en) | 1978-04-28 |
FR2236505A1 (en) | 1975-02-07 |
FI213974A (en) | 1975-01-14 |
IE39872B1 (en) | 1979-01-17 |
HU169791B (en) | 1977-01-28 |
FR2236505B1 (en) | 1977-07-08 |
DK133051B (en) | 1976-03-15 |
FI54131B (en) | 1978-06-30 |
CS182260B2 (en) | 1978-04-28 |
JPS5032160A (en) | 1975-03-28 |
AU477010B2 (en) | 1976-10-14 |
ATA575574A (en) | 1978-05-15 |
AU7112374A (en) | 1976-01-15 |
CH609064A5 (en) | 1979-02-15 |
IL45259A (en) | 1977-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES428226A1 (en) | 1,3-oxygenated 8alpha-oestratrienes | |
ES396708A1 (en) | Prostaglandin esters and production thereof | |
ES373752A1 (en) | Total steroid synthesis employing substituted isoxazole derivatives | |
GB1530913A (en) | Copying materials | |
GB1445956A (en) | Esters of dihydroapovincaminic acid | |
ES425088A1 (en) | Acidic oleo-acrylic resins and processes for preparing same | |
GB1360164A (en) | 3,5-dialkyl-4-hydroxyphenylalkanoic acid esters of hydroxyalkyl hydroxyalkanoates | |
JPS57206616A (en) | Menses inducer, feticidal or odynopoeia containing prostaglandin e1 analog | |
ES429020A1 (en) | Certain 2-alkyl-5-oxymethylthiazoles | |
ES436218A1 (en) | Phenoxyalkanol derivatives and a process for their preparation | |
GB1073272A (en) | Process for the manufacture of amino-organosilanes | |
ES432238A1 (en) | Analogues of prostanoic acids | |
ES415611A1 (en) | N-substituted prostaglandin carboxamides | |
ES428829A1 (en) | A procedure for the preparation of an ester composition. (Machine-translation by Google Translate, not legally binding) | |
ES432262A1 (en) | Procedure for obtaining eteres and esters of 3, 3- difenol-2-indolinone. (Machine-translation by Google Translate, not legally binding) | |
ES390920A1 (en) | Procedure for the preparation of 4,5 alpha - oxide - gufa-20,22-dienolid-3- (ramnosido 2'83 '- dialcohilortocarbonatos). (Machine-translation by Google Translate, not legally binding) | |
ES412799A1 (en) | Alpha-aminoalkyl-4-hydroxy-3-alkylsulphonylmethylbenzyl alcohols | |
GB1435892A (en) | Aluminium complexes of guaiphenesin | |
GB1347589A (en) | Dehydrocardenolides | |
ES428016A1 (en) | A procedure to prepare new amino acids. (Machine-translation by Google Translate, not legally binding) | |
GB1179474A (en) | 6beta,7beta-Methylene-9beta,10&alpha-Steroids, their preparation, and Compositions containing them | |
ES375209A1 (en) | A procedure for the preparation of cyclopropanocarboxylic acid steriors. (Machine-translation by Google Translate, not legally binding) | |
ES423976A1 (en) | Procedure for the preparation of new bencilamines. (Machine-translation by Google Translate, not legally binding) | |
ES350667A3 (en) | Procedure for the obtaining of electro-insulating varnishes. (Machine-translation by Google Translate, not legally binding) | |
GB1198146A (en) | 21-Ethers of 21-Hydroxy-delta<16>-Steroids of the Pregnane Series |